ELECSYS FERRITIN
Report
- Report Number
- 1823260-2023-00761
- Event Type
- Malfunction
- Date Received
- March 10, 2023
- Date of Event
- February 8, 2023
- Report Date
- April 12, 2023
- Manufacturer
- ROCHE DIAGNOSTICS
- Product Code
- JMG
- UDI-DI
- 04015630939688
- PMA / PMN Number
- K971833
- Removal / Correction Number
- NA
- Product Problem
- Yes
- Report Source
- Manufacturer report
- Reporter Location
- GM
- Reporter Occupation
- OTHER HEALTH CARE PROFESSIONAL
- Health Professional
- Yes
Narratives
THE QCS WERE IN RANGE. THE LEVEL 1 CALIBRATION AND LEVEL 2 CALIBRATION RESULTS WERE SLIGHTLY BELOW THE APPROXIMATE EXPECTED RANGE. THE INVESTIGATION IS ONGOING.
THE MOST OBSERVED ALARM IN THE ALARM TRACE WAS "REAGENT PROBE LIQUID-LEVEL DETECTION (LLD)". THIS SUGGESTS A PRE-ANALYTIC REAGENT HANDLING ISSUE. A GENERAL REAGENT ISSUE WAS NOT IDENTIFIED. THE INVESTIGATION DID NOT IDENTIFY A PRODUCT PROBLEM. THE CAUSE OF THE EVENT COULD NOT BE DETERMINED.
THE INITIAL REPORTER RECEIVED A QUESTIONABLE ELECSYS FERRITIN (FERRITIN) RESULT FROM ONE PATIENT SAMPLE TESTED ON THE COBAS E 801 ANALYTICAL UNIT WITH SERIAL NUMBER 20X6-04. THE INITIAL RESULT WAS REPORTED TO THE MEDICAL PERSONNEL AND WAS REJECTED AS IT DID NOT FIT THE MEDICAL STATE AND THE PREVIOUS RESULTS OF THE PATIENT. THE INITIAL RESULT OF THE UNDILUTED SAMPLE WAS 64.5 NG/ML. THE FIRST REPEAT RESULT OF THE UNDILUTED SAMPLE WAS 2000 NG/ML WITH A DATA FLAG. THE SECOND REPEAT RESULT USING A DILUTED SAMPLE WAS 4370 NG/ML. THIS REPEAT RESULT WAS DEEMED CORRECT AS IT IS IN LINE WITH THE PREVIOUS RESULTS AND THE CLINICAL PICTURE.
Devices
| Seq | Brand | Generic | Product Code | Manufacturer | Model | Lot | UDI-DI |
|---|---|---|---|---|---|---|---|
| 1182126 | ELECSYS FERRITIN | FERRITIN IMMUNOLOGICAL TEST SYSTEM | JMG | ROCHE DIAGNOSTICS | NA | 65213901 | 04015630939688 |
Patients
| Seq | Age | Sex | Outcome | Treatment |
|---|---|---|---|---|
| 1 | Unknown |